Magpale, Nicasio R.

HRN: 22-61-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/05/2025
12/12/2025
IV
2.25g
Q6h
CAP-MR; NONHEALING WOUND, LEFT
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: No  Wrong Dose 

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: